Roche diagnostics corp:1106277 [16-046343]

Ended Awarded Last action

Contract number
HHSN26100036
Awardee
Awarding agency
Obligated
$21,544

Award facts

Opportunity
Contract value 100% obligated
$21,544.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$2,340
Original award $23,885

About this award

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on June 21, 2016, with a ceiling value of $21,544.48 for in vitro diagnostic products and laboratory supplies. This is a firm fixed-price delivery order with no set-aside. Place of performance is Bethesda, MD. The order is due for ultimate completion on June 23, 2016.

Quick answers

Who was awarded contract HHSN26100036?

HHSN26100036 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on June 21, 2016.

How much is contract HHSN26100036 worth?

The government has obligated $21,544 on HHSN26100036.

Is contract HHSN26100036 an order under another contract?

Yes. HHSN26100036 is a delivery order under HHSN261201500001I, an indefinite delivery contract.

Was contract HHSN26100036 competed?

The extent of competition for HHSN26100036 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award